Evonik

Evonik invests in Chinese 3D-printing start-up making medical implants

Posted on Updated on

According to Ken Jin, co-founder, and chief technology officer of Meditool, “Meditool is one of the pioneers in developing 3D printed PEEK medical implants. Evonik has been our trusted partner in materials supply. The venture investment will be an extra boost to our endeavor to bring innovative solutions to patients and surgeons in China and the rest of the world.”
Evonik’s venture capital arm has already invested in two funds in China and with Meditool, it now has its first direct investment. Co-investors in Meditool include ZN Ventures, Morningside Ventures, and Puhua Capital.

Evonik invests in Chinese 3D-printing start-up making medical implants

EVONIK

Advertisements

Evonik’s €400 million project

Posted on Updated on

Whenever plastics are exposed to high stress, polyamide 12 from Evonik is the answer- in oil and gas extraction, automotive engineering, medical devices, or 3D printing. Evonik produces the high-performance plastic in two forms-as it is VESTAMID line of granulates and it’s VESTOSINT powder.

According to Dr. Ralf Düssel, the Head of the High-Performance Polymers Business Line at Evonik, “This project is a special challenge, the Group’s PA12 granules, and powders. This Evonik’s engineering unit has some 80 engineers are working on the project. We have also contracted a well-known, globally active technical service provider for the detail engineering of individual sub-projects. The Marl Chemical Park offers us optimal conditions for this extraordinary feat. Once we start up the new facility, the existing structures that have been in place for over 50 years will be used for product distribution.”

https://corporate.evonik.com/en/pages/article.aspx?articleId=107796

http://www.evonik.com